Zydus Wellness Ltd (ZYDUSWELL) is currently trading at 527.40 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Zydus Wellness Limited is a prominent Indian consumer wellness company specializing in health and wellness products. Its portfolio includes well-known brands like Sugar Free, Complan, Everyuth, and Glucon-D. The company continues to show robust international growth, with significant expansion in Europe through its acquisition of Comfort Click. This strategic acquisition has allowed Zydus to access new wellness markets across Europe. Financially, Zydus Wellness has shown impressive growth, with net sales for Q3 FY26 increasing by 113.7% year-on-year. The company's food and nutrition segment thrived with a 134% increase, although personal care slightly dipped. Zydus Wellness has demonstrated strong innovation, with new product developments in both domestic and international markets, such as Nutrarlite's new mayonnaise variants and Comfort Click’s diverse gummy supplements. Despite these growth areas, the company faced a net loss this quarter, greatly influenced by acquisition-related costs, which management assures will be cash EPS accretive in the medium to long term.

Over the past 52 weeks, Zydus Wellness Ltd has traded between a low of ₹357.55 and a high of ₹610.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Zydus Wellness Ltd has a market capitalization of approximately 16,857.75. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Zydus Wellness Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 89.57 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 16,857.75 Cr, Zydus Wellness Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Zydus Wellness Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Zydus Wellness Ltd is 89.57. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Standalone net sales in March 2026 were ₹132.6 crore, up 71.1% year-on-year from ₹77.5 crore in March 2025.

Zydus Lifesciences raised the buyback price to ₹1,260 per equity share from the earlier ₹1,150 per share.

The company reported consolidated net sales of INR 8,577 million in Q1 FY26, with net sales growth of 2.2% year on year.

Revenue rose 16.2% to ₹7,587 crore, EBITDA increased 20.2% to ₹2,554 crore, and EBITDA margin expanded to 33.7% from 32.6%.